Boss John G. reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director John G. Boss received a grant of 3,461 Restricted Stock Units (RSUs). Each RSU represents the economic equivalent of one share of Calumet common stock. Following this award, he holds 3,461 RSUs directly.
The RSUs vest upon the earlier of June 2, 2027 or the date Calumet holds its 2027 Annual Meeting, and will be settled in shares when they vest. This is a compensation-related equity award rather than an open‑market stock purchase or sale.
Quintana Julio M reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Julio M. Quintana reported an equity compensation grant of 3,461 Restricted Stock Units (RSUs), each equal to one share of common stock. The RSUs vest on the earlier of June 2, 2027 or the company’s 2027 annual meeting and are settled in shares upon vesting. Following this grant, Quintana holds 3,461 RSUs directly, with no open-market buy or sell activity disclosed.
Mawer Stephen P reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Stephen P. Mawer received a grant of 6,092 Restricted Stock Units (RSUs). Each RSU represents one share of common stock. The RSUs vest on the earlier of June 2, 2027 or the company’s 2027 annual meeting, and will be settled in shares at vesting. Following this grant, Mawer holds 6,092 RSUs directly.
Schumacher Amy M reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Amy M. Schumacher received a grant of 3,461 Restricted Stock Units on June 2, 2026. Each unit is the economic equivalent of one share of Calumet common stock, par value $0.01 per share.
The RSUs vest on the earlier of June 2, 2027 or the date of Calumet’s 2027 Annual Meeting, and will be settled upon vesting. Following this compensation award, Schumacher holds 3,461 RSUs directly.
Sajkowski Daniel J reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Daniel J. Sajkowski received a grant of 3,461 Restricted Stock Units, each economically equivalent to one share of common stock. This is a stock-based compensation award rather than an open-market trade. Following the grant, he holds 3,461 units directly.
The Restricted Stock Units vest on the earlier of June 2, 2027 or the date of Calumet, Inc.’s 2027 Annual Meeting, and will be settled in shares upon vesting. This aligns director compensation with future company performance over the next several years.
NARWOLD KAREN G reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Karen G. Narwold received a grant of 3,461 Restricted Stock Units on June 2, 2026. Each unit is the economic equivalent of one share of Calumet common stock. These RSUs vest on the earlier of June 2, 2027 or the company’s 2027 Annual Meeting and will be settled in shares upon vesting.
Calumet, Inc. reported voting results from its 2026 Annual Meeting of Stockholders held on June 2, 2026. Stockholders elected three Class II directors—Todd Borgmann, Daniel J. Sajkowski, and Bradford T. Sanders—to serve until the 2029 annual meeting.
Support for the director nominees ranged from 50,332,470 to 51,130,433 votes in favor, with 19,926,638 broker non-votes recorded for each nominee. Stockholders also approved, on a non-binding advisory basis, the Company’s executive compensation, with 50,222,235 votes for, 956,685 against, and 276,087 abstentions.
In addition, stockholders ratified the selection of Grant Thornton LLP as the independent registered public accounting firm for the year ending December 31, 2026, receiving 70,973,872 votes for, 194,987 against, and 212,786 abstentions.
Mawer Stephen P reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Stephen P. Mawer reported receiving two grants of restricted stock units on May 28, 2026. He was awarded 322 restricted stock units and a separate grant of 968 units, each economically equivalent to one share of common stock.
The 322 restricted stock units are 100% vested and will be settled in shares upon the earlier of a date he specifies or his termination date. The 968 restricted stock units will be settled under the Deferred Compensation Plan on the earlier of a specified date or termination, with 25% vesting each July 1 beginning in 2027.
Boss John G. reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director John G. Boss reported compensation-related equity grants. On 2026-05-28, he received two awards totaling 281 Restricted Stock Units, each economically equivalent to one share of Calumet common stock.
One 70-unit award is 100% vested and will be settled upon the earlier of a date he specifies or his termination date. The 211-unit award is granted under the Deferred Compensation Plan, with 25% of the units vesting on July 1 each year beginning on July 1, 2027, and settlement also occurring upon the earlier of his specified date or termination.
Raymond Paul C reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Raymond Paul C reported compensation-related equity grants. On May 28, 2026, he received two awards of Calumet Restricted Stock Units (RSUs) that are each economically equivalent to common shares of Calumet, Inc. common stock.
The first grant covers 234 RSUs, is 100% vested, and results in total holdings of 234 RSUs from that award. The second grant covers 704 RSUs, with 25% vesting each July 1 beginning on July 1, 2027, and total holdings of 704 RSUs from that award.
Both RSU awards have a grant price of $0.00 per unit and will settle in stock upon the earlier of a date specified by the reporting person or his termination date under the company’s deferred compensation plan.